Janumet and Aplastic anemia - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Janumet?
Janumet has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is used in diabetes. Currently, eHealthMe is studying from 24,143 Janumet users.
What is Aplastic Anemia?
Aplastic anemia is found to be associated with 1,441 drugs and 847 conditions by eHealthMe. Currently, we are studying 14,117 people who have Aplastic anemia.
Do you take Janumet and have Aplastic anemia?Check whether Aplastic anemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Janumet side effects by duration, gender and age:
- Janumet side effects (24,143 reports)
Aplastic anemia treatments and more:
- Aplastic anemia (14,117 reports)
All the drugs that are associated with Aplastic anemia:
All the conditions that are associated with Aplastic anemia:
How the study uses the data?
The study uses data from the FDA. It is based on metformin hydrochloride; sitagliptin phosphate (the active ingredients of Janumet) and Janumet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Colace and Moviprep drug interaction - a second ago
- Kerlone and Multaq drug interaction - 2 seconds ago
- Amlodipine Besylate and Injection Site Irritation - 2 seconds ago
- Luvox and Interstitial Lung Disease - 5 seconds ago
- Temazepam and Dermatitis Contact - 5 seconds ago
- Cotrim and Sleep Disorder - 8 seconds ago
- Lyrica and Vivelle drug interaction - 9 seconds ago
- Lyrica and Full Blood Count Abnormal - 10 seconds ago
- Colchicine and Gastrointestinal Inflammation - 12 seconds ago
- Nicotine Polacrilex and Sleep Disorder - 13 seconds ago